title: Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland?
abstract: In Switzerland, the incidence of equine botulism and acute pasture myodystrophy have remarkably increased in the last five years. Equine fodder-borne botulism in Europe is most likely caused by Clostridium botulinum types C and D that produce the toxins BoNT/C and BoNT/D. Horses showing signs suggestive of botulism (muscle weakness and tremors, reduced tongue tone, slow chewing, salivation and difficulties swallowing, drooping eyelids, mydriasis), especially patients that have fed on suspect fodder (mostly haylage), must be treated with anti-serum as soon as possible. They also need intensive care, which is often difficult to provide and always expensive in the face of a guarded to poor prognosis. Therefore, prevention (high standards of forage quality and vaccination) is all the more important. Pasture myodystrophy is an acute disease with signs of rhabdomyolysis and lethality rate over 90%. It affects grazing horses under frosty, windy and rainy conditions. Preliminary results indicate that Clostridium sordellii and Clostridium bifermentans producing lethal toxin may play a role in pasture myodystrophy. Our efforts concentrate on developing a new subunit vaccine for equine botulism and understanding the ethiology and pathogenesis of pasture myodystrophy with the goal of improving prevention against these highly fatal diseases that present a significant risk to our horse population.
authors.affiliation: Equine Clinic, Department of Clinical Veterinary Medicine, Vetsuisse-Faculty University of Berne, Switzerland. vinzenz.gerber@knp.unibe.ch
authors.forename: V
authors.initials: V
authors.lastname: Gerber
authors.forename: R
authors.initials: R
authors.lastname: Straub
authors.forename: J
authors.initials: J
authors.lastname: Frey
mesh_terms: D000821:Animal Feed / Q000009:adverse effects / Q000382:microbiology / Q000592:standards; D000818:Animals; D001428:Bacterial Vaccines; D001905:Botulinum Toxins / Q000009:adverse effects / Q000096:biosynthesis; D001906:Botulism / Q000175:diagnosis / Q000517:prevention & control / Q000662:veterinary*; D003014:Clostridium botulinum / Q000472:pathogenicity*; D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D006734:Horse Diseases / Q000175:diagnosis / Q000382:microbiology* / Q000517:prevention & control; D006736:Horses; D009137:Muscular Dystrophy, Animal / Q000175:diagnosis / Q000382:microbiology* / Q000517:prevention & control; D012988:Soil Microbiology; D013557:Switzerland
chemical_list: D001428:Bacterial Vaccines; D001905:Botulinum Toxins